Početna › Srpasto stanica › Illinois
Kliničke studije za Srpasto stanica u državi Illinois
19 studija za Srpasto stanica traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
Službeni tekst studije (engleski)
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
- University of Illinois at Chicago College of Medicine, Chicago
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT04055818A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Uni of Illinois Hospital and HSC, Chicago
U tijeku regrutacijaFaza 3
Od 12 do 100 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- University of Illinois Hospital and Health Sciences System, Chicago
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Univer Of Illinois at Chicago, Chicago
U tijeku regrutacijaFaza 3
Od 2 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Childrens Hospital of Chicago, Chicago
- Univer Of Illinois at Chicago, Chicago
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT06612268Tocilizumab for Acute Chest Syndrome
- University of Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT05640271A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0034, Chicago
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT06481306A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- University of Illinois at Chicago Clinical Research Center, Chicago
- University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
U tijeku regrutacijaFaza 2/3
Od 12 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Rush University Medical Center, Chicago
- Bleeding and Clotting Disorders Institute, Peoria
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 17. kol 2026. · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Illinois at Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 14. kol 2026. · NCT06699849The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
U tijeku regrutacijaFaza 3
Od 10 do 65 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06975865Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
- University of Illinois at Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 16 do 60 godina · Oba spola · Ažurirano 8. srp 2026. · NCT03121001Sickle Cell Clinical Research and Intervention Program
- Children's Hospital of Illinois at OSF-Saint Francis Medical Center, Peoria
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 4. lip 2026. · NCT02098863Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Comer Children's Hospital (MRD-HCT), Chicago
U tijeku regrutacijaOpažajna studija
Od 3 do 20 godina · Oba spola · Ažurirano 4. lip 2026. · NCT06941389Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
- University of Illinois Chicago, Sickle Cell Center, Chicago
U tijeku regrutacijaFaza 2
Od 18 do 60 godina · Oba spola · Ažurirano 19. svi 2026. · NCT07175051Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- University of Illinois at Chicago, Chicago
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 23. ožu 2026. · NCT06919224Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 2 do 25 godina · Oba spola · Ažurirano 10. ožu 2026. · NCT03587272Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacija
Od 16 do 30 godina · Oba spola · Ažurirano 7. sij 2026. · NCT06374238Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Illinois, Chicago
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 22. lip 2025. · NCT06385886Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.